EVALUATION OF THE EFFECT OF INTERLEUKIN-2 ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL BLOOD LYMPHOCYTES ON CHRONIC HEPATITIS B / 解放军医学杂志

24 patients with chronic hepatitis B were treated with interleukin-2 activated human peripheral blood lymphocytes (IAPBL). 23 patients served as control. The results showed that HBeAg disappeared in 54.2% of IAPBL group, in comparison with 17.4% of the controls (P